The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Therapeutic strategies for metaplastic breast cancer: A clinicopathologic analysis of a single institution cohort.

Hemali  Batra-Sharma

Stock and Other Ownership Interests  - Johnson & Johnson (I)

Consulting or Advisory Role - MJH Life Sciences

Kay T  Yeung

Research Funding - BioFluidica (Inst); Immunomedics/Gilead (Inst); Ionis Pharmaceuticals (I); Kaneka Corporation (I); Zymeworks (Inst)

Rebecca Arielle  Shatsky

Honoraria - AstraZeneca; Relevate Health; SOTERIA Precision Medicine; The Dedham Group

Consulting or Advisory Role - OncoSec; Puma Biotechnology; SOTERIA Precision Medicine; The Dedham Group

Speakers' Bureau - Gilead Sciences

Research Funding - Genentech (Inst); Merck (Inst); OBI Pharma (Inst); OncoSec (Inst); Oncternal Therapeutics (Inst); Phoenix Molecular Designs (Inst); QuantumLeap Health (Inst)